Julia Hoveyan
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Julia Hoveyan
Jun 14, 2024, 01:01 |
Insight
Julia Hoveyan: Join us on June 20th for the NORCaN Monthly Meeting
Julia Hoveyan, Pediatric Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared…
May 30, 2024, 10:57 |
Insight
Julia Hoveyan: A year ago, the IMMONC launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia
Ruzanna Papyan recently shared a post by Julia Hoveyan, Pediatric Oncologist at the Pediatric Cancer…
May 23, 2024, 03:02 |
Blog
Gevorg Tamamyan: Never compromise your values! Pediatric oncologists are rebels - 5-year report and a farewell note
Gevorg Tamamyan shared on LinkedIn: "Exactly five years ago, I was appointed the Head of…
Feb 8, 2024, 16:56 |
Blog
IV Armenian Oncology Congress: 6 tweets from Shushan Hovsepyan
Shushan Hovsepyan, Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center,…
Nov 26, 2023, 17:53 |
Blog
Ruzanna Papyan: An excellent meeting organized by iPOG
Ruzanna Papyan, Pediatric Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared…
Oct 28, 2023, 16:09 |
Career
Julia Hoveyan: Maybe tomorrow that brain tumor will be curable, and we need to do our best to achieve that
Julia Hoveyan, Pediatric oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared…
Oct 22, 2023, 17:06 |
Insight
Julia Hoveyan: The first comprehensive analysis of pediatric and young adult CNS tumors in Armenia over the last 26 years.
Julia Hoveyan, Paediatric Oncologist at Paediatric Cancer and Blood Disorders Centre of Armenia, shared a…
Sep 5, 2023, 17:56 |
Positive
Using this opportunity, we remind once again that love is contagious, not cancer. - Pediatric Cancer and Blood Disorders Center of Armenia
In a post by Pediatric Cancer and Blood Disorders Center of Armenia, it says: "Within…
All:
8
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube